Optimization of a small molecule inhibitor of secondary nucleation in α-synuclein aggregation

Parkinson’s disease is characterised by the deposition in the brain of amyloid aggregates of α-synuclein. The surfaces of these amyloid aggregates can catalyse the formation of new aggregates, giving rise to a positive feedback mechanism responsible for the rapid proliferation of α-synuclein deposit...

Full description

Bibliographic Details
Main Authors: Roxine Staats, Z. Faidon Brotzakis, Sean Chia, Robert I. Horne, Michele Vendruscolo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-08-01
Series:Frontiers in Molecular Biosciences
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1155753/full